Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)

Published:2014-12-11 Issue:2 Volume:172 Page:484-493
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Blauvelt A.¹,Prinz J.C.²,Gottlieb A.B.³,Kingo K.⁴,Sofen H.⁵,Ruer-Mulard M.⁶,Singh V.⁷,Pathan R.⁷,Papavassilis C.⁸,Cooper S.⁹,

Affiliation:

1. Oregon Medical Research Center; 9495 SW Locust Street, Suite G Portland OR 97223 U.S.A

2. Department of Dermatology and Allergology; Ludwig-Maximilians-University; Munich Germany

3. Tufts Medical Center; Boston MA U.S.A

4. Department of Dermatology and Venereology; University of Tartu; Tartu Estonia

5. Department of Medicine/Dermatology; UCLA School of Medicine; Los Angeles CA U.S.A

6. Le Bâteau Blanc-Imm. A; Centre Médical; Martigues Bouches-du-Rhône France

7. Novartis Healthcare Private Limited; Hyderabad India

8. Novartis Pharma AG; Basel Switzerland

9. Novartis Pharmaceuticals Corporation; East Hanover NJ U.S.A

Funder

Novartis

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.13348/fullpdf

Reference32 articles.

1. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses;Zaba;J Exp Med,2007

2. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells;Lowes;J Invest Dermatol,2008

3. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis;Kryczek;J Immunol,2008

4. Circulating Th17, Th22, and Th1 cells are increased in psoriasis;Kagami;J Invest Dermatol,2010

5. Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity;Zhang;Clin Immunol,2010

Cited by 294 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of reporting and concordance between sources of adverse events in the treatment of moderate-to-severe psoriasis: a cross-sectional study of RCTs from a Cochrane systematic review;Journal of Clinical Epidemiology;2024-09

2. A Comprehensive Review of the Factors Affecting the Redefinition of Therapeutic Use in Metropolitan Cities during the Emerging and Re-emerging Pandemics;Romanian Journal of Military Medicine;2024-09-01

3. Investigating EGFR, BRAF, and RAS Mutations in Oral and Cutaneous Squamous Cell Neoplasms: A Preliminary Report on Romanian Patients;Romanian Journal of Military Medicine;2024-09-01

4. Guselkumab Reduces Disease- and Mechanism-Related Biomarkers More Than Adalimumab in Patients with Psoriasis: A VOYAGE 1 Substudy;JID Innovations;2024-09

5. Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis;Expert Opinion on Drug Safety;2024-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3